The Commission has today agreed with BioNtech-Pfizer to accelerate the delivery of its mRNA vaccine to Member States, starting in a few weeks. In Q1 of 2022, BioNtech-Pfizer will deliver an additional 20 million vaccine doses (5 million in January, 5 million in February and 10 million in March). These doses come on top of…
The European Commission has signed a third contract with the pharmaceutical companies BioNTech and Pfizer. It reserves an additional 1.8 billion doses on behalf of all EU Member States, between end 2021 to 2023. It will allow for the purchase of 900 million doses of the current vaccine and of a vaccine adapted to variants,…
“The COVID-19 pandemic remains a severe threat to people’s health and livelihoods. We are in a race against time. The faster we reach our target of having 70% of adults in the European Union vaccinated, the better chances we have of containing the virus.” “And the good news is: Vaccination is picking up speed across…
Since the end of November, flights to more than 40 destinations have been carried out to distribute Pfizer-BioNTech’s COVID-19 vaccine from Belgium. This includes shipments via DHL Express and on commercial flights. As the most important hub serving the pharmaceutical industry in Europe, Brussels Airport has fully deployed its expertise in the transport of temperature-sensitive pharmaceutical…
Consider this: on the day the UK announced it had given the coronavirus jab to 1.5m of its citizens, there were some EU member states yet to vaccinate a single one of their citizens. These included The Netherlands, which has always prided itself on its healthcare system but neighbouring Belgium also pretty much matched the…
The European Commission on Friday proposed to the EU Member States to purchase an additional 200 million doses of the COVID-19 vaccine produced by BioNTech and Pfizer, with the option to acquire another 100 million doses. This would enable the EU to purchase up to 600 million doses of this vaccine, which is already…
The European Commission has approved a fifth contract with the European pharmaceutical company CureVac, which provides for the initial purchase of 225 million doses on behalf of all EU Member States, plus an option to request up to a further 180 million doses, to be supplied once a vaccine has proven to be safe and…
